X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Share Price    (AIDL)

Here is the latest stock price and chart of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Aug 21, 2019 (Close)
Price (Rs)1,700.25 Open (Rs) 1,756.65 High (Rs) 1,815.00 Low (Rs) 1,668.00
% Change-4.17 Volume 1,000 Value (Rs) 1,746,954 52-Week H/L 2,398.55 / 1,306.80
Live NSE Quotes Aug 21, 2019 (Close)
Price (Rs)1,699.10 Open (Rs) 1,745.00 High (Rs) 1,818.00 Low (Rs) 1,690.10
% Change-3.80 Volume 19,620 Value (Rs) 34,068,147 52-Week H/L 2,397.70 / 1,306.05
Valuation
EPS (Rs)* 27.83 P/E Ratio (x) 61.10 Market Cap (Rs m) 42,506.25 P/BV (x) 17.21
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Special: Your Chance to Witness a Rare Investing Opportunity Ends in 2 Days


Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

ASTRAZENECA PHARMA Share Price Today:

ASTRAZENECA PHARMA last traded price was down 4.2% to Rs 1,700.3 on the BSE. On the NSE, ASTRAZENECA PHARMA last traded price was down 3.8% to Rs 1,699.1. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.0%. And the benchmark S&P BSE SENSEX was at 37,060.4 (down 0.7%).

Over the last 30 days, the ASTRAZENECA PHARMA share price is down 8.3%. And over the last one year, ASTRAZENECA PHARMA share price is down 6.8%.





Today's Market

Sensex Ends 267 Points Lower; Metal and Capital Goods Stocks Witness Huge Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 267 points (down 0.7%).

Related Views On News

EDELWEISS FINANCIAL Plunges by 5%; BSE 500 Index Down 0.1% (Market Updates)

Aug 21, 2019 | Updated on Aug 21, 2019

EDELWEISS FINANCIAL share price has plunged by 5% and its current market price is Rs 120. The BSE 500 is down by 0.1%. The top gainers in the BSE 500 Index are JAGRAN PRAKASHAN (up 5.6%) and MAHINDRA CIE AUTO. (up 4.4%). The top losers are EDELWEISS FINANCIAL (down 5.4%) and ASTRAZENECA PHARMA (down 6.0%).

ASTRAZENECA PHARMA Plunges by 6%; BSE HEALTHCARE Index Down 0.1% (Market Updates)

Aug 21, 2019 | Updated on Aug 21, 2019

ASTRAZENECA PHARMA share price has plunged by 6% and its current market price is Rs 1,757. The BSE HEALTHCARE is down by 0.1%. The top gainers in the BSE HEALTHCARE Index are BIOCON (up 2.7%) and ALEMBIC PHARMA (up 2.2%). The top losers is ASTRAZENECA PHARMA (down 6.0%)..

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

The Perfect Stock in the Rebirth of India (The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too (The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Smallcaps that Will Outperform in the Market Rebound (Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - TEVA PHARMA COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS